Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Invectys S.A.
DescriptionPeptide-based vaccine consisting of a pool of CD4-specific telomerase peptides
Molecular Target Telomerase reverse transcriptase (TERT) ; CD4
Mechanism of Action 
Therapeutic ModalityPreventive vaccine: Peptide vaccine
Latest Stage of DevelopmentPreclinical
Standard Indication Cancer (unspecified)
Indication DetailsTreat cancer
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today